Advisory Board May 8, 2024

After the COVID-19 pandemic, interest in mRNA vaccines jumped, and many pharmaceutical companies are now testing the technology against other diseases, including cancer. Although data on mRNA cancer vaccines is still preliminary, some health experts say they could be “gamechangers in immunotherapy.”

Truly personalized care is possible. Here’s how to make it a reality.

How mRNA vaccines could help fight cancer

Although vaccines against infectious diseases are used as a preventive measure, cancer vaccines are primarily used as treatments. Cancer vaccines target antigens on tumor cells so the immune system will recognize and destroy them.

Currently, there are two types of mRNA cancer vaccines in development: “bespoke” or personalized vaccines that are tailored to a specific target or “off-the-shelf” vaccines...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Healthcare System, Pharma / Biotech, Public Health / COVID
CNS-Focused Rapport Therapeutics Preps IPO to Back Phase 2-Ready Epilepsy Drug
Balancing Weight-loss Medication Cost and Care
Marijuana rescheduling moves businesses into ‘uncharted territory’
Orforglipron: the new kid on the GLP-1 block
GLP-1 Agonist Safety Risks and Obesity Stigma with Kevin Peterson, MD, MPH

Share This Article